Executive team

Shivang, a bioengineer and nanotechnologist, has also been passionately involved with global health. He earned his BS and PhD in Bioengineering from UC Berkeley and UW Seattle, respectively. As a NSF Graduate Fellow, he focused on the development of nanoparticle-based probes for the solution-phase multiplexed, ultrasensitive detection of cancer biomarkers. He was awarded the College of Engineering Community of Innovators Dean’s Award and completed the Program in Technology Commercialization and Technology Entrepreneurship Certificate (Foster Business School, Center for Innovation & Entrepreneurship). Shivang has co-developed commercial strategies to numerous technologies, including drug-eluting intraocular lenses to reduce post-surgery infection burden in developing countries such as India, for which was awarded Best Innovation and Finalist Prizes at various business plan competitions.

Shivang’s LinkedIn page

Daryl has been involved in both technical and business ends of the biomedical industry. He received a B.S. in Physics from the University of Leipzig and a Ph.D. in Biomedical Engineering from Boston University. Following that, he did a postdoctoral fellowship at MIT where he developed diagnostic devices for ophthalmology and oncology. More recently, he joined a management consulting firm, serving a variety of clients including some of the largest companies in the med-tech, healthcare, and pharma space.

Daryl’s LinkedIn page

Eduardo Lage, a native of Spain, received his undergraduate degree in Electronic Engineering from the University of Alcala (Madrid) and his PhD in Medical Imaging from the University Politecnica of Madrid. He began his career in Medical Imaging by joining the Medical Imaging Lab of the Gregorio Marañon Hospital to help in the development of a Positron Emission Tomography (PET) system for small-animal imaging. From that time, Eduardo Lage has focused his career on exploring innovative approaches for molecular imaging. Dr. Lage has led or participated in the design and development of various preclinical scanners (PET, SPECT, CT and multimodality systems) which have been commercialized by several companies such as SEDECAL S.A. (Madrid) and General Electric (USA).

Eduardo’s LinkedIn page

Nick is an optical engineer with academic and industry experience in clinical and commercial translation of innovative technologies. He has a B.S. in Electrical Engineering and Computer Science from U.C. Berkeley, a Ph.D. in Biomedical Engineering from U.T. Austin, and completed his Postdoctoral Training at Harvard Medical School. He previously worked in the advanced technology group at Nellcor Puritan Bennett, where he developed opto-electronic medical devices. From 2011 to 2014, he was an M+Vision Fellow at MIT, where he was the principal investigator of research projects in endoscopy and ocular diagnostics.

Nick’s LinkedIn page

Engineering and R&D team

Carlos Hernandez Santiago

Director of Engineering

Marcos Rubio

Algorithms Engineer

Aaron Chang, MSE

Design & Human Factors Engineer

Ignacio Casares

Software Engineer


Ethis Healthtech, LLC, serves early-stage and emerging firms in the fields of eyecare and mobile/digital healthcare by providing market entry planning and support, and strategic communications. Working with both pre-revenue and later-stage firms, the Ethis Healthtech team can draw upon decades of experience in ophthalmology and optometry, technology and commercialization, construction of go-to-market strategies, management of sales teams, and implementation of all aspects of marketing and communications. With a deep network among ophthalmic and digital health multinationals, clinical key opinion leaders, and investors, Ethis Healthtech supports all aspects of its clients’ growth activities.

Aurolab, based in southern part of India, is an integral part of the Aravind Eye Care System. It manufactures a wide range of high quality ophthalmic consumables such as intraocular lenses, surgical sutures, pharmaceutical products, surgical blades and equipments. Aurolab’s mission is to eliminate needless blindness by making high quality ophthalmic products affordable and accessible to vision impaired world wide.

Advisors & Collaborators

  • Luca Sergio

    CEO & Owner at Ethis, Managing Partner, Ethis Healthtech, LLC

  • Oscar Lazaro

    Chief Commercial Officer of Medimaps Group

  • David Green

    Leading Social Entrepreneur in the global health space

  • Prof. Frank Thorn

    Professor of Vision Science at New England College of Optometry and faculty member at the Wenzhou Medical University in China

  • Prof. Susana Marcos

    Professor and Director of the Visual Optics & Biophotonics Lab at the Institute of Optics (CSIC) in Madrid

  • Prof. Fuensanta Vera-Diaz

    Professor of Optometry at the New England College of Optometry

  • Dr Srinivas M Sastry

    Chair of Ophthalmology at Suburban Hospital, Bethesda, Maryland

  • Mounir Ouhadi, ME, MBA

    Advisor for Operations and Supply Chain

  • Carlos Dorronsoro

    Senior scientist at the Visual Optics and Biophotonics Lab, CSIC